Emerging approaches for the therapy of autoimmune and chronic inflammatory disease
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 16 (6) , 780-786
- https://doi.org/10.1016/j.coi.2004.09.005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Pathogenic Roles of B Cells in Human AutoimmunityImmunity, 2004
- B cell depletion therapy in systemic lupus erythematosusCurrent Rheumatology Reports, 2003
- Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritisArthritis & Rheumatism, 2003
- BAFF and APRIL: A Tutorial on B Cell SurvivalAnnual Review of Immunology, 2003
- The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosusArthritis & Rheumatism, 2003
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002
- Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionAnnals of the Rheumatic Diseases, 2002
- Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytesRheumatology, 2001
- Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20Blood, 1994